Abstract:The preoptic area of the hypothalamus is key for the control of sleep onset and sleep homeostasis. Although traditionally considered exclusively somnogenic, recent studies identified a group of preoptic glutamatergic neurons that promote wakefulness. Specifically, our previous investigations demonstrated that chemogenetic stimulation of glutamatergic neurons within the medial-lateral preoptic area (MLPO_VGLUT2) promotes wakefulness, fragments non-rapid eye movement sleep (NREMs), and suppresses REM sleep (REMs). This evidence is further supported by recent work showing that preoptic glutamatergic neurons are activated during microarousals that fragment sleep in response to stress, and optogenetic stimulation of these neurons promotes microarousals and wakefulness. Thus, while the wake-promoting function of MLPO_VGLUT2 is clear, their role in sleep homeostasis has not been assessed. We tested the hypothesis that MLPO_VGLUT2 are wake-active, and their activation will increase wakefulness and disrupt sleep homeostasis via projections to arousal-promoting systems. Using fiber photometry, we found that MLPO_VGLUT2 were highly active during REMs, wakefulness and brief arousals, and remained minimally active during NREMs. Chemogenetic stimulation of MLPO_VGLUT2 inhibited REMs onset and suppressed the REMs homeostatic response after total sleep deprivation. Chemogenetic inhibition of MLPO_VGLUT2 increased REMs time (during the light phase only) but did not influence REMs and NREMs homeostasis. Anterograde projection mapping revealed that MLPO_VGLUT2 innervate central regions that promote wakefulness and inhibit REMs. We conclude that MLPO_VGLUT2 powerfully suppress REMs and that exogenous (and possibly pathologic) activation of these neurons disrupts REMs recovery, presumably by directly or indirectly activating REMs-inhibitory mechanisms.

Paraventricular hypothalamic nucleus are essential for arousal promotion and maintenance

Dysfunctions of the paraventricular hypothalamic nucleus induce hypersomnia in mice

Glutamatergic Neurons of the Paraventricular Nucleus Are Critical for the Control of Wakefulness.

Medial Parabrachial Nucleus Is Essential in Controlling Wakefulness in Rats

Activation of Ventral Pallidum CaMKIIa-Expressing Neurons Promotes Wakefulness

Ventral pallidal GABAergic neurons control wakefulness associated with motivation through the ventral tegmental pathway

Whole-Brain Mapping of Direct Inputs to and Axonal Projections from GABAergic Neurons in the Parafacial Zone

Basal Forebrain Parvalbumin Neurons Mediate Arousals from Sleep Induced by Hypercarbia or Auditory Stimuli

Control of wakefulness by lateral hypothalamic glutamatergic neurons in male mice

Nucleus accumbens controls wakefulness by a subpopulation of neurons expressing dopamine D1 receptors.

The paraventricular thalamus is a critical thalamic area for wakefulness

Ventral subiculum promotes wakefulness through several pathways in male mice

Parasubthalamic calretinin neurons modulate wakefulness associated with exploration in male mice

A Role of Prefrontal Cortico-Hypothalamic Projections in Wake Promotion.

Distinct Hypothalamic Paraventricular Nucleus Inputs to the Cingulate Cortex and Paraventricular Thalamic Nucleus Modulate Anxiety and Arousal.

Regulation of REM Sleep Onset and Homeostasis by Preoptic Glutamatergic Neurons

Norepinephrine modulates wakefulness via α1 adrenoceptors in paraventricular thalamic nucleus

Nucleus Accumbens Corticotropin-Releasing Hormone Neurons Projecting to the Bed Nucleus of the Stria Terminalis Promote Wakefulness and Positive Affective State

Ventral pallidal glutamatergic neurons regulate wakefulness and emotion through separated projections

CaMKIIa Neurons of the Ventromedial Hypothalamus Mediate Wakefulness and Anxiety-like Behavior

Superior Colliculus GABAergic Neurons Are Essential for Acute Dark Induction of Wakefulness in Mice